Induced Pluripotent Stem Cells Market Report

Global and Region Induced Pluripotent Stem Cells Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：227
  • REPORT CODE：GMM1009009
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Induced Pluripotent Stem Cells market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Induced Pluripotent Stem Cellsmarket, defines the market attractiveness level of Induced Pluripotent Stem Cells market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Induced Pluripotent Stem Cells industry, describes the types of Induced Pluripotent Stem Cells market, the applications of major players and the market size, and deeply analyzes the current situation of the global Induced Pluripotent Stem Cells market and the development prospects and opportunities of Induced Pluripotent Stem Cells industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Induced Pluripotent Stem Cells market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb Company

    • Astellas Pharma

    • Acelity Holdings

    • Celgene Corporation

    • StemCells

    • Japan Tissue Engineering

    • Organogenesis

    • ViaCyte

    • Fate Therapeutics

    • Fujifilm Holding Corporation

    • Aastrom Biosciences

    By Type:

    • Hepatocytes

    • Fibroblasts

    • Keratinocytes

    • Amniotic Cells

    • Others

    By End-User:

    • Academic Research

    • Drug Development And Discovery

    • Toxicity Screening

    • Regenerative Medicine

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Induced Pluripotent Stem Cells Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Induced Pluripotent Stem Cells Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Induced Pluripotent Stem Cells Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Induced Pluripotent Stem Cells Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Induced Pluripotent Stem Cells Market Analysis and Outlook to 2022

    • 7.1 Global Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.2 United States Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.3 Europe Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.4 China Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.5 Japan Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.6 India Induced Pluripotent Stem Cells Consumption (2017-2022)

    • 7.7 South Korea Induced Pluripotent Stem Cells Consumption (2017-2022)

    8 Region and Country-wise Induced Pluripotent Stem Cells Market Analysis and Outlook to 2028

    • 8.1 Global Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.2 United States Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.3 Europe Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.4 China Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.5 Japan Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.6 India Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    • 8.7 South Korea Induced Pluripotent Stem Cells Consumption Forecast (2022-2028)

    9 Global Induced Pluripotent Stem Cells Market Outlook by Types and Applications to 2022

    • 9.1 Global Induced Pluripotent Stem Cells Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hepatocytes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Fibroblasts Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Keratinocytes Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Amniotic Cells Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Induced Pluripotent Stem Cells Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Academic Research Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Development And Discovery Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Toxicity Screening Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Regenerative Medicine Consumption and Growth Rate (2017-2022)

    10 Global Induced Pluripotent Stem Cells Market Outlook by Types and Applications to 2028

    • 10.1 Global Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hepatocytes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Fibroblasts Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Keratinocytes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Amniotic Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Academic Research Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug Development And Discovery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Toxicity Screening Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Regenerative Medicine Consumption Forecast and Growth Rate (2022-2028)

    11 Global Induced Pluripotent Stem Cells Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Induced Pluripotent Stem Cells Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Induced Pluripotent Stem Cells Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Induced Pluripotent Stem Cells Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Induced Pluripotent Stem Cells Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Details

      • 14.1.2 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Product and Service

    • 14.2 Astellas Pharma

      • 14.2.1 Astellas Pharma Company Details

      • 14.2.2 Astellas Pharma Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Astellas Pharma Induced Pluripotent Stem Cells Product and Service

    • 14.3 Acelity Holdings

      • 14.3.1 Acelity Holdings Company Details

      • 14.3.2 Acelity Holdings Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Acelity Holdings Induced Pluripotent Stem Cells Product and Service

    • 14.4 Celgene Corporation

      • 14.4.1 Celgene Corporation Company Details

      • 14.4.2 Celgene Corporation Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Celgene Corporation Induced Pluripotent Stem Cells Product and Service

    • 14.5 StemCells

      • 14.5.1 StemCells Company Details

      • 14.5.2 StemCells Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 StemCells Induced Pluripotent Stem Cells Product and Service

    • 14.6 Japan Tissue Engineering

      • 14.6.1 Japan Tissue Engineering Company Details

      • 14.6.2 Japan Tissue Engineering Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Product and Service

    • 14.7 Organogenesis

      • 14.7.1 Organogenesis Company Details

      • 14.7.2 Organogenesis Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Organogenesis Induced Pluripotent Stem Cells Product and Service

    • 14.8 ViaCyte

      • 14.8.1 ViaCyte Company Details

      • 14.8.2 ViaCyte Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 ViaCyte Induced Pluripotent Stem Cells Product and Service

    • 14.9 Fate Therapeutics

      • 14.9.1 Fate Therapeutics Company Details

      • 14.9.2 Fate Therapeutics Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Fate Therapeutics Induced Pluripotent Stem Cells Product and Service

    • 14.10 Fujifilm Holding Corporation

      • 14.10.1 Fujifilm Holding Corporation Company Details

      • 14.10.2 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Product and Service

    • 14.11 Aastrom Biosciences

      • 14.11.1 Aastrom Biosciences Company Details

      • 14.11.2 Aastrom Biosciences Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Aastrom Biosciences Induced Pluripotent Stem Cells Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Induced Pluripotent Stem Cells

    • Figure Induced Pluripotent Stem Cells Picture

    • Table Global Induced Pluripotent Stem Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Induced Pluripotent Stem Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Induced Pluripotent Stem Cells Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Induced Pluripotent Stem Cells Consumption by Country (2017-2022)

    • Figure United States Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Table Europe Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure China Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Japan Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure India Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure South Korea Induced Pluripotent Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Induced Pluripotent Stem Cells Consumption Forecast by Country (2022-2028)

    • Figure United States Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Induced Pluripotent Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hepatocytes Consumption and Growth Rate (2017-2022)

    • Figure Global Fibroblasts Consumption and Growth Rate (2017-2022)

    • Figure Global Keratinocytes Consumption and Growth Rate (2017-2022)

    • Figure Global Amniotic Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Research Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Development And Discovery Consumption and Growth Rate (2017-2022)

    • Figure Global Toxicity Screening Consumption and Growth Rate (2017-2022)

    • Figure Global Regenerative Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Hepatocytes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fibroblasts Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Keratinocytes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Amniotic Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Development And Discovery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Toxicity Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Regenerative Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Induced Pluripotent Stem Cells Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Induced Pluripotent Stem Cells Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Induced Pluripotent Stem Cells Product and Service

    • Table Acelity Holdings (Foundation Year, Company Profile and etc.)

    • Table Acelity Holdings Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acelity Holdings Induced Pluripotent Stem Cells Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Induced Pluripotent Stem Cells Product and Service

    • Table StemCells (Foundation Year, Company Profile and etc.)

    • Table StemCells Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table StemCells Induced Pluripotent Stem Cells Product and Service

    • Table Japan Tissue Engineering (Foundation Year, Company Profile and etc.)

    • Table Japan Tissue Engineering Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Japan Tissue Engineering Induced Pluripotent Stem Cells Product and Service

    • Table Organogenesis (Foundation Year, Company Profile and etc.)

    • Table Organogenesis Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Organogenesis Induced Pluripotent Stem Cells Product and Service

    • Table ViaCyte (Foundation Year, Company Profile and etc.)

    • Table ViaCyte Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table ViaCyte Induced Pluripotent Stem Cells Product and Service

    • Table Fate Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Fate Therapeutics Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fate Therapeutics Induced Pluripotent Stem Cells Product and Service

    • Table Fujifilm Holding Corporation (Foundation Year, Company Profile and etc.)

    • Table Fujifilm Holding Corporation Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujifilm Holding Corporation Induced Pluripotent Stem Cells Product and Service

    • Table Aastrom Biosciences (Foundation Year, Company Profile and etc.)

    • Table Aastrom Biosciences Induced Pluripotent Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aastrom Biosciences Induced Pluripotent Stem Cells Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US